Autologous cellular therapy for myeloma: Giving ex vivo expanded NK cells their due

Ex vivo feeder-free autologous NK cell expansion is an efficient modality for clinical translation. In this issue of Cell Reports Medicine, Nahi et al. describe the use of this approach as consolidation therapy for multiple myeloma,(1) thereby reviving an alternate avenue for NK cell therapy.

Detalles Bibliográficos
Autores principales: Shapiro, Roman M., Romee, Rizwan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Preview
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8861944/
https://www.ncbi.nlm.nih.gov/pubmed/35243428
http://dx.doi.org/10.1016/j.xcrm.2022.100537
Descripción
Sumario:Ex vivo feeder-free autologous NK cell expansion is an efficient modality for clinical translation. In this issue of Cell Reports Medicine, Nahi et al. describe the use of this approach as consolidation therapy for multiple myeloma,(1) thereby reviving an alternate avenue for NK cell therapy.

Ejemplares similares